oral semaglutide glp-1 Medication Helps Patients Maintain Weight Loss | Newsroom What to Know About Semaglutide:

In the STEP-1 trial, participants achieved a mean weight loss of 6.0% by week 12 (during dose escalation) and 12.4% by week 28, with the full 14.9% mean loss reached at week 68 [1]

Side effects and tolerability issues associated with GLP-1 receptor agonists can limit the usage of these medications in the market

PlexusDx specializes in precision weight loss therapy with comprehensive medication interaction screening to ensure your treatment plan works safely alongside existing prescriptions

Williams Hematology

What are the risks of adding an unproven compound to a GLP-1 regimen

Sometimes, you might just want a protein shake